Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2026)

Rigel Pharmaceuticals' Inventory history runs 9 years deep, the most recent figure standing at $11.7 million for Q1 2026.

• In Q1 2026, Inventory rose 150.1% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $11.7 million (up 150.1% YoY), while the FY2025 annual figure was $11.5 million, up 91.7% from the prior year.
• Inventory was $11.7 million for Q1 2026 at Rigel Pharmaceuticals, up from $11.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $13.3 million in Q3 2025 to a low of $4.7 million in Q1 2025.
• Historically, Inventory has averaged $8.2 million across 5 years, with a median of $7.1 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Inventory plunged 40.61% in 2024, then soared 178.07% in 2025.
• A 5-year view of Inventory shows it stood at $9.1 million in 2022, then plunged by 39.44% to $5.5 million in 2023, then advanced by 8.69% to $6.0 million in 2024, then jumped by 91.7% to $11.5 million in 2025, then grew by 1.27% to $11.7 million in 2026.
• The last three Inventory figures came in at $11.7 million (Q1 2026), $11.5 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.